Clinical trial

Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

NCT00450749

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-02-01

PhasePHASE2

Study timeline

Study start (unknown)2008-02-01Date precision: month

Registry last updated2019-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adenocarcinoma of the Prostateunresolved

Stage I Prostate Cancerunresolved

Stage II Prostate Cancerunresolved

Stage III Prostate Cancerunresolved

Interventions

therapeutic conventional surgeryPROCEDURE

laboratory biomarker analysisOTHER

lycopeneDRUG · verified · RxNorm: lycopene

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00450749 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.